You couldn’t make it up: Covid mask maker Remote Monitored Systems delays production as staff catch er…Covid
By Tom Winnifrith, The Sheriff of AIM | Monday 1 February 2021
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Remote Monitored Systems (RMS) ’s Pharm2farm subsidiary has produced plenty of masks in trial runs so its staff should never have been short of protective masks to wear. So, on that basis, it’s not a great sales pitch is it: “our masks are so good our own staff caught and spread Covid.” No wonder this company has not got any customers.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.